Daniil Gataulin
Stock Analyst at Chardan Capital
(3.20)
# 1,092
Out of 4,641 analysts
41
Total ratings
35.14%
Success rate
7.5%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Daniil Gataulin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RGNX REGENXBIO | Maintains: Buy | $52 | $9.74 | +433.88% | 7 | Oct 22, 2024 | |
| CLSD Clearside Biomedical | Maintains: Buy | $6 | $1.14 | +428.63% | 2 | Oct 14, 2024 | |
| CRVO CervoMed | Initiates: Buy | $55 | $12.38 | +344.26% | 1 | Sep 18, 2024 | |
| FBRX Forte Biosciences | Maintains: Buy | $75 | $4.83 | +1,452.80% | 1 | Aug 19, 2024 | |
| OTLK Outlook Therapeutics | Maintains: Buy | $53 | $5.27 | +905.69% | 6 | Aug 16, 2024 | |
| MGTX MeiraGTx Holdings | Maintains: Buy | $36 | $5.85 | +515.38% | 1 | Jul 31, 2024 | |
| ADVM Adverum Biotechnologies | Maintains: Buy | $4 → $40 | $8.12 | +392.61% | 5 | Jul 18, 2024 | |
| EYPT EyePoint Pharmaceuticals | Maintains: Buy | $28 | $9.96 | +181.12% | 6 | Jun 28, 2024 | |
| OCS Oculis Holding AG | Reiterates: Buy | $30 | $16.26 | +84.50% | 3 | Jun 11, 2024 | |
| CGTX Cognition Therapeutics | Initiates: Buy | $11 | $0.60 | +1,733.33% | 1 | Jun 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 | $0.91 | +449.39% | 5 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $220 | $4.80 | +4,483.33% | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $3.54 | - | 2 | Jul 25, 2023 |
REGENXBIO
Oct 22, 2024
Maintains: Buy
Price Target: $52
Current: $9.74
Upside: +433.88%
Clearside Biomedical
Oct 14, 2024
Maintains: Buy
Price Target: $6
Current: $1.14
Upside: +428.63%
CervoMed
Sep 18, 2024
Initiates: Buy
Price Target: $55
Current: $12.38
Upside: +344.26%
Forte Biosciences
Aug 19, 2024
Maintains: Buy
Price Target: $75
Current: $4.83
Upside: +1,452.80%
Outlook Therapeutics
Aug 16, 2024
Maintains: Buy
Price Target: $53
Current: $5.27
Upside: +905.69%
MeiraGTx Holdings
Jul 31, 2024
Maintains: Buy
Price Target: $36
Current: $5.85
Upside: +515.38%
Adverum Biotechnologies
Jul 18, 2024
Maintains: Buy
Price Target: $4 → $40
Current: $8.12
Upside: +392.61%
EyePoint Pharmaceuticals
Jun 28, 2024
Maintains: Buy
Price Target: $28
Current: $9.96
Upside: +181.12%
Oculis Holding AG
Jun 11, 2024
Reiterates: Buy
Price Target: $30
Current: $16.26
Upside: +84.50%
Cognition Therapeutics
Jun 6, 2024
Initiates: Buy
Price Target: $11
Current: $0.60
Upside: +1,733.33%
May 15, 2024
Maintains: Buy
Price Target: $5
Current: $0.91
Upside: +449.39%
Mar 7, 2024
Maintains: Buy
Price Target: $220
Current: $4.80
Upside: +4,483.33%
Jul 25, 2023
Downgrades: Neutral
Price Target: n/a
Current: $3.54
Upside: -